Antonio Conde, oncologist: "If we do not name cancer, we stigmatize the patient"
Dr. Antonio Conde emphasizes the importance of addressing cancer openly and discusses advancements in proton therapy as a key to enhancing Spain's public healthcare system in the fight against cancer.
Antonio Conde, head of the Radiation Oncology Service at Hospital La Fe in Valencia, highlights the need for open discussions surrounding cancer to combat the stigma often associated with the disease. He argues that avoiding the term 'cancer' can perpetuate fear and misunderstanding, which affects patients' mental health and treatment journeys. Dr. Conde advocates for a proactive approach to naming and acknowledging cancer, believing that it can lead to better outcomes for patients.
Dr. Conde is also the coordinator of the national platform overseeing the implementation of proton therapy within the Spanish National Health System. He contends that proton therapy represents a significant advancement in cancer treatment, enabling more precise targeting of tumors while minimizing damage to surrounding healthy tissues. This innovation, he asserts, will position Spain at the forefront of cancer treatment in Europe, offering hope to patients diagnosed with various forms of the disease.
While Dr. Conde expresses optimism about the potential benefits of proton therapy in improving patient care and outcomes, he remains cautious about its implementation. He recognizes the challenges of integrating this new technology into clinical practice and emphasizes the need for comprehensive training and resources for healthcare providers. Dr. Conde's insights underscore the critical intersection of medical advancement and the importance of addressing cancer openly in society to reduce stigma and improve patient support.